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 2014 WilThe underlying etiologies of genetic congenital microcephaly are complex and multifactorial. Recently, with the
exponential growth in the identiﬁcation and characterization of novel genetic causes of congenital microcephaly,
there has been a consolidation and emergence of certain themes concerning underlying pathomechanisms.
These include abnormal mitotic microtubule spindle structure, numerical and structural abnormalities of the
centrosome, altered cilia function, impaired DNA repair, DNA Damage Response signaling and DNA replication,
along with attenuated cell cycle checkpoint proﬁciency. Many of these processes are highly interconnected.
Interestingly, a defect in a gene whose encoded protein has a canonical function in one of these processes can
often have multiple impacts at the cellular level involving several of these pathways. Here, we overview the key
pathomechanistic themes underlying profound congenital microcephaly, and emphasize their interconnected
nature. © 2014 Wiley Periodicals, Inc.KEYWORDS: cell division; mitosis; DNA replication; cilia
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Congenital microcephaly, an occipital‐
frontal circumference of equal to or less
than 2–3 standard deviations below the
age‐related population mean, denotes
a fundamental impairment in normal
brain development [Woods and Parker,
2013]. Depending on the underlying
cause, congenital microcephaly can be
associated with structural brain malfor-
mations [e.g., gyrification issues, agenesis
of corpus callosum, pituitary abnormal-
ities] or secondary consequences such as
craniosynostosis [Verloes et al., 2013].
Congenital microcephaly can have an
environmental or genetic etiology [Gil-
more and Walsh, 2013]. Cerebral corti-
cal neurons must have developed byor: Cancer Research UK; Grant spo
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ey Periodicals, Inc.mid‐gestation although glial cell division
and consequent brain volume enlarge-
ment does continue after birth [Spalding
et al., 2005]. Impaired neurogenesis is
therefore most obviously reflected clini-
cally as congenital microcephaly.
Fundamentally, neurogenesis incor-
porates several stages that are very
susceptible to problems in the efficient
and effective execution of genome
maintenance, DNA replication and
ultimately cell division. The developing
human neuroepithelium must undergo
a rapid expansion in stem cell numbers
to fuel its own symmetric expansion
[Rakic, 1995]. This is essential to
generate enough capacity to instigate
and maintain asymmetric division for
neuronal differentiation, enabling thensor: Medical Research Council (UK); Grant sponsor
uman Molecular Genetics in the Genome Damage
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rary (wileyonlinelibrary.com).formation of the various cortical layers.
Furthermore, differentiating and devel-
oping neurons must migrate to their
defined locations to construct the com-
plex architecture and laminar layered
structure of the cortex [Tan and Shi,
2013; Wu et al., 2014] (Fig. 1).
What spectrum of physiological
deficits underlies congenital microceph-
aly? Defects resulting in elevated levels of
apoptosis can deplete neuroprogenitor
stem and differentiating cells. Defects
impacting upon efficient DNA replica-
tion can limit the capacity of the
neuroepithelium to expand under its
strict temporal constraints. Defects in the
mitotic apparatus (e.g., microtubule
spindles, centrosomes, centrioles) can
lead to impaired symmetric‐asymmetric: Leukaemia Lymphoma Research (UK).
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de understanding the mechanisms underlying
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Figure 1. Cell division and differentiation in the developing cerebral cortex. (A). Neural plate originating cells initially undergo a phase
of symmetric self‐renewal and lateral expansion. Then, as development continues they asymmetrically divide to give rise to glial cells and
neurons in the cerebral cortex, which ultimately structures into multiple discrete layers following development. Radial glial cells are key
neuroprogenitors whose cell body lies in the ventricular zone (VZ) and whose radial fibers span the width of the cerebral cortex. These can
differentiate into neurons, as well as intermediate progenitors that migrate to the subventricular zone (SVZ) and can further generate more
progenitor cells and neurons by repeated asymmetric cell division. Finally, radial glial cells also can give rise to astrocytes and
oligodendrocytes at later stages. Additionally, the radial glial fibers function as scaffolding for migrating cells to move outwards and away
from the VZ to their appropriate destination regions. Ultimately the migrating neurons become the pyramidal cells of the cerebral cortex.
CP: cortical plate. IZ: intermediate zone. VZ: ventricular zone. OSVZ: outer‐subventricular zone. ISVZ, inner‐subventricular zone.
IZ: intermediate zone. (B) Neuroepithelial cell division within the ventricular zone (VZ) is accompanied by nuclear migration between
the apical and basal surfaces of the developing cerebral cortex. In the G1 phase of the cell cycle, the cell nucleus ascends from the apical
surface towards the basal end of the ventricular zone, where it remains during S‐phase. During G2, the nucleus then returns to the apical
surface where mitosis (M) takes place. (C) Proliferative versus neurogenic (differentiating) cell division is dictated by the cleavage plane
orientation (dotted red line) of dividing neuroepithelial (NE) cells. Orientation of the mitotic spindle is parallel to the apical surface during
symmetric cell division, with the resulting cleavage plan intersecting the apical plasmamembrane (PM). A deviation in the orientation of the
mitotic spindle results in an asymmetric cell division, with only one of the daughter cells inheriting the apical PM region (pink cell). The
correct orientation of the mitotic spindle is therefore crucial for neurogenesis. The number of rounds of symmetric proliferative divisions
undergone by NE cells determines the ultimate number of neurons. As neurogenesis progresses, increased asymmetric divisions means that
only one daughter cell inherits the apical PM and remains a NE cell, while the other becomes either a basal progenitor, a radial‐glial cell or a
neuron (depicted as the orange cell). Additionally, cell cycle length plays a role in proliferative versus differentiating cell divisions. Longer cell
cycles have been associated with differentiating divisions, while shortening of G1 phase for example has been linked to an increase in
proliferative divisions.
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and/or elevated apoptosis. Mutations
in genes encoding key players in each
of these biological processes have
been described in patients exhibit-
ing profound congenital microcephaly
(Tables I–III). This can present as the
most marked clinical feature; primary
microcephaly (PM), or in association
with pronounced growth restriction; as
in the growing family of geneticallyidentifiable microcephalic primordial
dwarfisms (MPDs), such as Seckel
syndrome, microcephalic primordial
dwarfism types I and II and Meier–
Gorlin syndrome. Herein, we overview
the genetic defects associated with severe
congenital microcephaly and discuss
how they contribute to the general
phenomena of limiting cell division
capacity and elevating levels of stem
and/or neuroprogenitor cell deathas mechanisms underlying impaired
neurogenesis.MITOSIS AND
MICROCEPHALY
To date, the majority of the genetic
defects identified in PM and MPDs
involve genes encoding proteins that
play fundamental roles in various pro-
cesses that collectively enable cells to
TABLE I. Centrosome and Spindle Microtubule Defects Underlying Severe Congenital Microcephaly
Gene Protein OMIM Clinical presentation Localization and function
MCPH1 Microcephalin 251200 PM. Cells exhibit premature
chromosome condensation
Centrosome‐role in DNA repair
and G2‐M dynamics
WDR62
(MCPH2)
WD‐repeat containing
protein 62
604317 PM Mitotic spindle pole formation‐scaffold
for JNK pathway
CDK5RAP2/
CEP215
(MCPH3)
Cyclin dependent kinase 5
regulatory subunit‐associated
protein 2
604804 PM Centrosome, spindle and microtubule
organizing function.
CASC5
(MCPH4)
Cancer susceptibility
candidate 5
604321 PM Kinetochore [KNM] component‐
spindle‐assembly checkpoint
ASPM
(MCPH5)
Abnormal spindle‐like,
microcephaly
associated
608716 PM Microtubule associated protein‐spindle
organization and orientation
CENPJ/CPAP
(MCPH6)
Centromeric protein J 608393 PM‐MPD‐Seckel syndrome Centriole biogenesis‐cilia formation
613676
STIL (MCPH7) SCL/TAL1 interrupting locus 612703 PM Centrosome‐centriole biogenegis
CEP135
(MCPH8)
Centrosomal protein 135kDa 614673 PM Centrosome‐centriole biogenegis
CEP152
(MCPH9)
Centrosomal protein
of 152 kDa
614852 PM‐MPD‐Seckel syndrome Centrosome‐centriole biogenesis
and genome stability
613823
CEP63 Centrosomal protein
of 63 kDa
614728 Microcephaly with growth
retardation‐Seckel
syndrome [mild]
Centrosome‐centriole biogenesis
NDE1 Nuclear distribution protein
nudE homolog 1
614019 Microlissencephaly
microhydraencephaly
Centrosome‐mitotic spindle
NIN Ninein 614851 MPD‐Seckel syndrome Centrosome function‐microtubule
organization
PCNT Pericentrin 210720 Microcephalic Osteodysplastic
Primordial Dwarfism (MOPD) II
Component of pericentriolar material‐
scaffold for signaling molecules?
BUB1B BUB1 Mitotic Checkpoint
Serine/Threonine
Kinase B1 (BUBR1)
257300 Growth retardation‐microcephaly‐
cancer‐Mosaic Variegated
Aneuploidy [MVA]
Kinetochore kinase‐role in spindle
checkpoint
CENPE Centromere protein E
(CENP‐E)
117143a MPD Microtubule capture
and stabilization
KIF5C Kinesin family member 5C 615282 Microcephaly and cortical
malformations
Microtubule motor protein
KIF2A Kinesin family member 2A 615411 Severe microcephaly‐cortical
malformations‐early‐onset epilepsy
Microtubule motor protein
KIF11 Kinesin family member 11 152950 Microcephaly with or without
chorioretinopathy, lymphoedema
and mental retardation
Microtubule motor protein‐role
in microtubule crosslinking
and bipolar spindle formation
TUBG1 Tubulin‐gamma complex
associated protein 1
615412 complex cortical malformations‐
microcephaly (not all reported
cases)
Structural component of the
centrosome‐role in microtubule
nucleation
TUBB2B Tubulin, beta 2B class IIb 610031 Microcephaly‐spastic
tetraparesis‐severe intellectual
disability‐scoliosis
Microtubule component‐binds
to GTP
TUBA1A Tubulin, alpha 1A 611603 Microcephaly‐severe
intellectual disability
Microtubule component
POC1A Proteome of the centriole 1A 614783 MPD Centriolar protein required for cilia
formation
PM, primary microcephaly; MPD, microcephalic primordial dwarfism.
aDenotes the gene entry in OMIM.
TABLE II. Defects in the Origin Recognition Complex Core and Associated Components Underlying Meier–Gorlin
Syndrome
Gene Protein OMIM Clinical presentation Localization & function
ORC1 Origin recognition
complex subunit 1
224690 Meier–Gorlin syndrome Component of the pre‐replication
complex‐initiation of DNA replication
ORC4 Origin recognition
complex subunit 4
613800 Meier–Gorlin syndrome Component of the pre‐replication
complex‐initiation of DNA replication
ORC6 Origin recognition
complex subunit 6
613803 Meier–Gorlin syndrome Component of the pre‐replication
complex‐initiation of DNA replication,
coordination of chromosome‐replication
and segregation
CDT1 Chromatin licensing and
DNA replication factor 1
613804 Meier–Gorlin syndrome Component of the pre‐replication complex
‐origin licensing factor
CDC6 Cell division cycle 6 613805 Meier–Gorlin syndrome Component of the pre‐replication
complex‐loading MCM complex‐role in
cell cycle checkpoints
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tion and mitotic division [Thornton andTo date, the majority of the
genetic defects identified in
PM and MPDs involve genes
encoding proteins that play
fundamental roles in various
processes that collectively
enable cells to execute precise
chromosomal segregation
and mitotic division.Woods, 2009; Mahmood et al., 2011;
Verloes et al., 2013](Table I). The
mitotic phase of the cell cycle involves
an intricate and highly complex ballet of
interactions and transactions occurring
in an organized and inter‐dependent
fashion [Walczak et al., 2010]. These
include chromosome condensation,
bipolar mitotic microtubule spindle
network formation and dissolution,
along with chromosomal kinetochore‐
mediated nucleation and capture by
spindle microtubules to instigate the
amphitelic restraining of chromosomes
for alignment at metaphase prior to
segregation. The centrosome representsan important spindle microtubule orga-
nizing center [Bettencourt‐Dias and
Glover, 2007]. There is now an increas-
ing list of examples of hypomorphic
defects in genes encoding core compo-
nents of the centrosome associated
with PM and MPD (Table I and
Figs. 2 and 3).
Very often, the precise roles of these
proteins at centrosomes are rather opa-
que. For some, such as Pericentrin and
g‐tubulin, these often have “structural”
or “scaffold” functions attributed them
[Zimmerman et al., 2004]. In most
instances, descriptive impacts upon cen-
triole and centrosome duplication, and
consequently abnormalities in micro-
tubule spindle organization, have been
observed for defects in these proteins
[Griffith et al., 2008; Rauch et al., 2008].
Furthermore, there is growing evidence
that defects in some of these proteins
have additional negative impacts upon
the centrosomal localization of other
centrosome proteins that have indepen-
dently been identified as underlying
defects of PM and/or MPD. Illustrative
examples include the interplay between
CEP152 and CEP63 or for CEP152
and CENPJ (CPAP) [Cizmecioglu et al.,
2010; Sir et al., 2011]. These occur-
rences further highlight the intercon-
nected and functional interplay between
many of these proteins, explaining to
some degree why defects herein presentwith a common clinical manifestation of
congenital microcephaly.Centrosomes and Spindles
The centrosome cycle is coordinated
with the canonical cell cycle whereby
the mother centrosome, inherited fromCurrently, the working
functional model to explain
impaired neurogenesis in the
context of a defect in a
centrosomal protein is that
these often result in
supernumerary centrosomes,
fragmented centrosomes
and/or premature centriolar
separation. Consequently,
these can result in deficits in
mitotic spindle microtubule
nucleation when establishing a
bipolar spindle.the previous mitosis, must duplicate to
generate a mother‐daughter pair prior
to G2‐phase where they then act as a
microtubule organizing center at the
TABLE III. Defects in DNA Damage Response and DNA Repair Proteins Associated With Congenital Microcephaly
Gene Protein OMIM Clinical presentation Localization & function
ATR Ataxia telangiectasia and
rad3‐related
210600 MPD–Seckel syndrome Protein kinase‐apical DDR regulator‐cell cycle
checkpoint activation‐role in DNA replication
ATRIP ATR‐interacting protein 606605a MPD–Seckel syndrome Essential ATR partner‐binds to RPA‐coated
ssDNA‐DDR‐role in DNA replication
RBBP8/
CTIP
Retinoblastoma‐binding
protein 8/CTBP‐interacting
protein (CtIP)
606744 MPD–Seckel syndrome DNA DSB resection‐role in ATR recruitment to
DSBs‐associates with BRCA1 in regulation of
cell cycle checkpoints
NBS1/
NBN
Nijmegen breakage
syndrome 1 /nibrin
251260 Nijmegen breakage syndrome (NBS):
microcephaly‐immunodeficiency‐
cancer predisposition
Component of M‐R‐N complex with central
role in DNA DSB repair
RAD50 DNA repair protein RAD50 613078 NBS‐like disorder: microcephaly‐
intelletual disability‐“bird‐like”
face‐short stature
Component of M‐R‐N complex with central
role in DNA DSB repair
MRE11A Double‐strand break
repair protein MRE11A
600814a NBS‐like severe microcephaly Component of M‐R‐N complex with central
role in DNA DSB repair
PNKP Bifunctional polynucleotide
phosphatase and kinase
613402 Microcephaly‐seizures‐developmental
delay
Role in DNA repair pathways (NHEJ, BER)
CDK6 Cyclin‐dependent kinase 6 603368a PM Control of cell cycle and differentiation‐
centrosomal association in mitosis
BRCA1 Breast cancer type 1
susceptibility protein
113705a Microcephaly‐short stature‐developmental
delay‐cancer predisposition
DNA repair‐cell cycle checkpoint control‐
maintenance of genomic stability (HRR)
BRCA2 Breast cancer type 2
susceptibility protein
600185a MPD DNA repair‐cell cycle checkpoint control‐
maintenance of genomic stability (HRR)
LIG4 DNA ligase 4 606593 Ligase IV syndrome: microcephaly‐
dysmorphic facial features‐growth
retardation‐skin anomalies‐
pancytopenia.
DNA DSB repair (NHEJ) and V(D)J
recombination
NHEJ1 Non‐homologous
end‐joining factor 1
611291 Growth retardation‐microcephaly‐
immunodeficiency
DNA DSB repair (NHE)] and V(D)J
recombination
CHLR1/
DDX11
DEAD/H (Asp‐Glu‐Ala‐
Asp/Hi)
box helicase 11
601150a Warsaw breakage syndrome [WABS]:
microcephaly‐pre‐ and postnatal
growth retardation‐abnormal skin
pigmentation
DNA helicase‐genome stability
PHC1
(MCPH11)
Polyhomeotic‐like protein 1 615414 PM‐short stature Component of polycomb group (PcG)
multiprotein PRC1‐like complex/ repression
of transcription/role in chromatin remodelling
and histone modification
DNA2 DNA replication helicase 2 601810a MPD Helicase‐DNA repair‐genome stability
XRCC2 X‐ray repair complementing
defective repair in Chinese
hamster cells 2
600375a Microcephaly‐growth deficiency‐facial
nerve palsy‐skeletal abnormalities
DNA DSB repair (HR)‐genome stability
XRCC4 X‐ray repair complementing
defective repair in Chinese
hamster cells 4
194363a MPD DNA DSB repair (NHEJ)‐genome stability
NHEJ1 Nonhomologous end‐joining
factor 1.
Also called XLF/
Cernnunos
611291 Severe combined immunodeficiency
(SCID)‐microcephaly‐growth
retardation‐IR sensitivity
DNA DSB repair [NHEJ]‐genome stability
RECQL3 Bloom syndrome helicase
(BLM)
210900 Bloom syndrome‐microcephlay‐growth
delay‐immune deficiency‐cancer
HRR pathway HJ resolving helicase
PM, primary microcephaly; IR, ionizing radiation.
aDenotes the gene entry in OMIM. MPD: microcephalic primordial dwarfism. HRR: homologous recombination repair. NHEJ: non‐
homologous DNA end joining. M‐R‐N: MRE11‐RAD50‐NBS1 complex.
Figure 3. The distribution of genetic defects underlying congenital microcephaly attributable to the centrosome, spindle and
kinetochore. The upper panel depicts a normal bipolar mitosis. For the centrosome panel, the proteins in black are centrosome‐specific
proteins whilst those in blue are spindle constituent and spindle‐associated proteins associated with congenital microcephaly. For the
kinetochore panel CENP‐E is shown extending from the kinetochore via its large coiled‐coiled region onto microtubules. The orange
section of CENP‐E denotes its kinesin motor domain. CCAN: constitutive centromere‐associated network. KNM network: KNL1‐
NDC80 (CASC5)‐MIND.
Figure 2. Centrioles, centrosome and mitotic microtubule organization. (A) The centriole cycle is intimately coordinated with the
canonical cell cyclewhere centriolar division occurs during S‐phase to ensuremature centrioles are available prior to the onset of mitosis. (B)
A normal mitosis is depicted in the upper panel where the centrosomes are shown in black, the chromosomes in gray and the microtubule
spindles as the dotted lines. Bi‐polar spindle formation is an essential prerequisite to effective chromosome segregation during mitotic
division. The lower panels show mitotic LCLs from a wild‐type (WT) and PCNT‐mutated individual. The spindles were detected using
a‐tubulin (green) whilst the centrosomes were stained using g‐tubulin (yellow‐orange). The WT mitotic cell shows a bipolar spindle in
contrast to the multipolar spindle from the PCNT‐individual. (Images courtesy of Dr. Iga Abramowicz).
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2001] (Fig. 2A). Currently, the working
functional model to explain impaired
neurogenesis in the context of a defect in
a centrosomal protein is that these often
result in supernumerary centrosomes,
fragmented centrosomes and/or prema-
ture centriolar separation [Woods and
Parker, 2013]. Consequently, these can
result in deficits in mitotic spindle
microtubule nucleation when establish-
ing a bipolar spindle. Very often,
multipolar spindles are observed in
patient‐derived cell lines representing a
catastrophic consequence for mitosis,
chromosome segregation and cell divi-
sion [Rauch et al., 2008; Issa et al., 2013]
(Fig. 2B). Such outcomes can result in
permanent cell cycle arrest via activation
of the spindle assembly checkpoint
(SAC), as well as cytokinesis failure
and subsequent apoptosis [Musacchio,
2011]. All of these impacts could limit
neuroepithelial stem cell maintenance
and expansion, as well as disrupt the
important balance between cell division
and differentiation (Fig. 1).
Defects in microtubule spindle
components and spindle‐associated pro-
teins represent the most frequent under-
lying cause of congenital microcephaly
described to date (Table I). One well
known example is ASPM (abnormal
spindle‐like microcephaly‐associated
protein), a spindle binding protein that
localizes to the pericentriolar matrix
(PCM) of the centrosome at the onset of
mitosis [Bond et al., 2002]. It has been
shown that defects in ASPM function
can result in altered spindle pole orien-
tation in the developing neuroepithe-
lium, thereby disrupting the balance
between symmetric and asymmetric
division of neuronal stem cells [Fish
et al., 2006] (Fig. 1C). Indeed this has
also recently been elegantly demonstrat-
ed in the developing brain of a mouse
model of Mcph1 (Microcephalin), a
common cause of PM in humans
[Gruber et al., 2011]. Defects in micro-
tubule and cytoskeletal constituents
(e.g., a‐ and b‐tubulin) and even
microtubule interacting proteins that
regulate diverse processes such as micro-
tubule formation, stabilization and de-
polymerization, can also result incongenital microcephaly [Morris‐Rose-
ndahl et al., 2008; Jaglin and Chelly,
2009; Romaniello et al., 2014] (Table I
and Fig. 3). These defects are typically
also associated with marked deficits in
cortical development (e.g., lissencephaly,
pachygyria, polymicrogyria) due to
abnormalities in neuronal migration
(e.g., KIF2A, KIF5C) [Poirier et al.,
2013].The Kinetochore and Spindles
Considering its role in microtubule
capture and chromosome segregation,
defects in kinetochore components as an
underlying pathomechanism for con-
genital microcephaly are very much
under‐represented to date, compared
to the spindle and centrosome (Table I
and Fig. 3). Mutations in BUB1B cause
mosaic variegated aneuploidy, an MPD
associated with elevated cancer predis-
position, particularly Wilms tumor
[Matsuura et al., 2000; Hanks et al.,
2004]. BUB1B encodes BUBR1, a SAC
protein that localizes to the kinetochore
of lagging chromosomes during mitosis
[Bolanos‐Garcia et al., 2009; Kiyomitsu
et al., 2011]. SAC activation ensures all
kinetochores have robust amphitelic
microtubule attachments prior to segre-
gation [Rudner and Murray, 1996;
Musacchio, 2011].
A defect in CASC5 was reported
in three related families used to define
the original MCPH4 locus [Jamieson
et al., 1999; Genin et al., 2012]. CASC5
encodes a component of the KMN
Complex [KNL1‐Mis12 complex‐
Ndc80], a kinetochore localizing
multi‐protein complex involved in mi-
crotubule stabilization and SAC silenc-
ing [Kiyomitsu et al., 2007]. Mirzaa et al.
[2014] recently described the first ex-
ample of a defect in a core kinetochore
component as the underlying cause of
MPD. They found defects in CENPE,
the gene encoding the large kinetochore
protein CENP‐E which plays a vital role
in microtubule capture during mitosis
(Fig. 3). Cells from the affected individ-
uals exhibited multiple interconnected
mitotic abnormalities. It is likely that
other kinetochore‐associated defects
await to be identified as novel causes ofcongenital microcephaly disorders, as
PM and/or MPD.DNA REPLICATION, CILIA
FUNCTION AND
MICROCEPHALY
Compared to other cell types, cell cycle
length can be remarkably short in
developing neuroprogenitors [Rakic,
1995]. Since these cells need to undergo
rapid and temporally restricted expan-
sion, efficient DNA replication is fun-
damental to ensure normal neuronal
development. In fact, even within
progenitor populations there appears to
be significant variation in the duration of
certain cell cycle phases; most notably
G1 and S‐phase, depending upon the
specific lineage commitment of the
progenitors in question [Dehay et al.,
2001; Dehay and Kennedy, 2007; Pilaz
et al., 2009; Arai et al., 2011]. Therefore,
genetic defects that can adversely impact
upon the duration of these cell cycle
phases could potentially have a dramatic
effect upon the efficiency of cortical
development.Origin Licensing, G1‐S Transition,
DNA Replication and S‐Phase
Progression
Recently, defects in multiple compo-
nents of the origin recognition complexRecently, defects in multiple
components of the origin
recognition complex [ORC],
a multi‐subunit complex that
‘licenses’ and thereby initiates
DNA replication from mainly
non‐sequence specific discrete
genomic regions, were
identified in Meier‐Gorlin
syndrome (MGS).[ORC], a multi‐subunit complex that
“licenses” and thereby initiates DNA
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specific discrete genomic regions, were
identified in Meier‐Gorlin syndrome
(MGS) [Bicknell et al., 2011a,b; Guern-
sey et al., 2011] (Table II). MGS is an
MPD associated with additional features
including endochondral ossification ab-
normalities [Gorlin et al., 1975; Ahmad
and Teebi, 1997; Bongers et al., 2005].
With respect to ORC1‐mutated MGS,
specific deficiencies in DNA origin
licensing, DNA replication initiation,
G1‐S transition and S‐phase progression
were catalogued in patient lymphoblas-
toid cell lines (LCLs), thus suggesting a
pathomechanism based upon delayed
DNA replication as underlying the
clinical presentation [Bicknell et al.,
2011b]. Furthermore, several ORC1‐
MGS mutations localized to the BAH
(bromo adjacent homology) domain of
ORC1 [Bicknell et al., 2011b]. This
region was shown to bind histone H4‐
lysine‐20‐dimethylated (H4‐K12‐Me2),
and since H4‐K12‐Me2 is enriched at
two known human replication origins,
it has been postulated that this domain
is required for ORC‐recruitment to
origins [Noguchi et al., 2006; Kuo
et al., 2012]. Collectively, these findings
appear to support a model whereby a
direct impact upon DNA replication
kinetics, due to defects in components
that initiate DNA replication, are asso-
ciated with congenital microcephaly in
the context of this MPD.
Recent findings suggest that there is
more to this basic model. For example,
pathogenic defects in MCM4, a core
component of the replisome, have
been identified in patients with adrenal
insufficiency, growth restriction and a
selective Natural Killer cell defect,
although without any overt indication
of congenital microcephaly [Casey et al.,
2012; Gineau et al., 2012; Hughes
et al., 2012]. Similarly, a polymerase‐
inactivating defect in the catalytic sub-
unit (POLD1) of DNA polymerase d,
the lagging strand DNA polymerase,
has been identified in an individual with
a complex disorder involving lipodys-
trophy, deafness, hypogonadism and
mandibular hypoplasia; again, without
overt congenital microcephaly [Weedon
et al., 2013].Cilia‐Function and S‐Phase Entry
With respect to the impaired origin
licensing and delayed S‐phase kinetics
observed in MGS, subsequent investiga-
tion provided evidence to suggest a more
complex and multifaceted pathome-
chanism. Stiff et al. [2013] found that
while MGS‐causative defects were asso-
ciated with reduced licensing of an
ectopically supplied DNA replication
origin, unexpectedly, some of these
defects did not segregate with delayed
S‐phase progression in patient LCLs.
Rather, all of these defects were associ-
ated with centriole‐centrosome abnor-
malities, impaired cilia formation and
consequently cilia‐dependent signaling
[Stiff et al., 2013]. Interestingly, ORC1
can localize to the centrosome in a
Cyclin A‐dependent manner and has
previously been implicated in control-
ling centriole and centrosome copy
number via interaction with Cyclin E
[Hemerly et al., 2009]. Whether other
ORC components have direct roles at
the centrosome and/or cilia is not clear.
Cilia formation and function are
vital for coordinating cell cycle entry
from G0 phase into G1‐S [Heldin and
Westermark, 1999; Schneider et al.,
2005]. Furthermore, cilia function is
intimately associated with neuronal
development [Spassky et al., 2008; Han
and Alvarez‐Buylla, 2010; Lee and
Gleeson, 2011]. Delayed G1‐S transit
appears to be a feature of MGS cells and
this delay appears also to be dependent
upon cilia‐signaling [Stiff et al., 2013].
This is an intriguing result considering
the importance of G1 phase length in
regulating the balance between neuro-
progenitor stem cell regeneration and
progenitor lineage commitment via
differentiation [Dehay and Kennedy,
2007; Pilaz et al., 2009]. The cilia‐
dependent findings in MGS originating
from defects in components with ca-
nonical roles in DNA replication adds an
extra layer of complexity to our under-
standing of the molecular and cellular
impacts that converge here to adversely
affect normal neuronal development
(and height attainment and endochon-
dral ossification). Additionally, several
ORC components have also beenimplicated in multiple post‐mitotic
neuronal functions, suggestive of addi-
tional roles outside of DNA replication
origin licensing (reviewed in Kerzen-
dorfer et al., 2013).
Is there precedence for centrosome‐
based cilia dysfunction in human con-
genital microcephaly disorders? Defects
in PCNT, encoding the centrosomal
protein Pericentrin, underlie the MPD
microcephalic primordial osteodysplas-
tic dwarfism type‐II (MOPD‐II) [Grif-
fith et al., 2008; Rauch et al., 2008].
Impaired PCNT function is associated
with cilia‐dysfunction [Miyoshi et al.,
2006, 2009; Mühlhans et al., 2011].
Multiple mutations in POC1A which
encodes a centriole protein, have been
identified in several MPD families
[Shaheen et al., 2012]. Interestingly
these defects were associated with
centrosome fragmentation, microtubule
spindle abnormalities (e.g., multipolar
spindles) as well as cilia formation and
signaling deficits [Shaheen et al., 2012].
In fact, ASPM has recently been
associated with compromised WNT
signaling which could also reflect an
underlying problem in cilia function
[Ponting, 2006; Buchman et al., 2011].
Therefore, it would appear that
clinically relevant cilia abnormalities
impacting on neurogenesis can originate
from at least two routes; firstly, as a direct
consequence of defects in proteins with
known and/or probable roles in cilia
formation which emanates from the
centriolar‐basal body, and secondly,
from the likely secondary or indirect
consequence of defects in proteins
without prescribed roles in the cilium
or in cilia formation, as in the case of the
origin licensing components. The latter
route may prove to be more widespread
than currently appreciated.THE DNA DAMAGE
RESPONSE (DDR) AND
MICROCEPHALY
The PI3‐kinase‐like family members
ATM (Ataxia Telangiectasia Mutated)
and ATR (Ataxia Telangiectasia and
Rad3‐related) are the apical protein
kinases of the DNA Damage Response
(DDR) [Cimprich and Cortez, 2008;
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Shiloh and Ziv, 2013]. The DDR is a
signal transduction cascade activated
upon detection of DNA strand breaks
that initiates and controls integrated
responses to these damages [Sirbu and
Cortez, 2013]. These responses include
cell cycle checkpoint activation, DNA
replication fork stabilization, engage-
ment of DNA repair pathways and
ultimately apoptosis, if the extent of
damage precludes survival. ATM is
activated by DNA double strand break-
age (DSB) while ATR is activated by
RPA‐coated single stranded DNA
(ssDNA) which can occur upon stalling
of DNA replication forks or as an
intermediate during certain DNA
repair processes (e.g., DSB resection
to facilitate homologous recombination
repair). Both kinases largely function
in a redundant manner in the DDR
[O’Driscoll and Jeggo, 2008].
Congenital deficiency of ATM
results in ataxia telangiectasia [A–T], a
cerebellar neurodegenerative condition
involving the progressive loss of Purkinje
neurons specifically [Lavin, 2008].
Hypomorphic defects in ATR underlie
Seckel syndrome; the archetypal MPDHypomorphic defects in ATR
underlie Seckel syndrome; the
archetypal MPD. ATR has
an obligate co‐stabilising
binding partner called ATRIP
(ATR‐Interacting Protein),
and defects herein have also
been identified as a cause of
Seckel syndrome.[O’Driscoll et al., 2003]. ATR has an
obligate co‐stabilizing binding partner
called ATRIP (ATR‐interacting pro-
tein), and defects herein have also been
identified as a cause of Seckel syndrome
[Ogi et al., 2012]. From an neuroana-
tomical perspective, impaired ATR‐
ATRIP function is most overtly
associated with marked congenitalmicrocephaly extending to 9 to 12
SD below the age related mean post‐
natally [Ogi et al., 2012]. Some
problems in myelination and isolated
structural abnormalities (e.g., absent
pituitary fossa, agenesis of corpus
callosum) have also been observed in
these patients, although not consistently
(Fig. 4A) [Ogi et al., 2012].
ATR plays a vital role in stabilising
stalled DNA replication forks [Cimprich
and Cortez, 2008]. Both ATM and ATR
function in controlling dormant DNA
replication origin firing and activation
of G1‐S, intra‐S and G2‐M cell cycle
checkpoints. One of the first bona fide
substrates identified and characterized
for these kinases was p53 [Banin
et al., 1998]. There are nowmany others
[Matsuoka et al., 2007; Stokes et al.,
2007]. Therefore, both kinases directly
signal to the apoptotic machinery via this
and other routes [Roos and Kaina,
2006]. Loss of ATR function is associat-
edwith elevated replication fork collapse
and consequently DSB formation,
therefore triggering an ATM‐dependent
DDR cascade. This was elegantly dem-
onstrated as a physiological consequence
of hypomorphic ATR‐ablation in a
mouse model of ATR‐mutated Seckel
syndrome (AtrS/S) [Murga et al., 2009].
Embryos of the AtrS/S animal exhibited
massively elevated spontaneous levels of
replicative stress‐induced DNA damage
and apoptosis, even in the developing
neuroepithelium [Murga et al., 2009].
The surviving animals exhibited cranio-
facial abnormalities (receding forehead,
micrognathia), growth restriction and
congenital microcephaly reminiscent of
the ATR‐mutated Seckel syndrome
individuals, consistent with the concept
of intrauterine programming [Murga
et al., 2009; O’Driscoll, 2009].Defective DDR, Apoptosis and
Microcephaly
Conditional Cre‐restricted mouse mod-
els have shown that the functional inter‐
relationships between in the apical DDR
kinases are more complex when consid-
ering brain development. For example,
conditional Atr ablation was unexpect-
edly found to impact relatively late uponneurogenesis, and then only in certain
progenitor populations [Lee et al.,
2012b]. Rapid proliferation of granule
neuronswithin the embryonic cerebellar
external germ layer (EGL) occurs in
response to sonic hedgehog (Shh),
whose mitogenic potential is realized
via cilia [Spassky et al., 2008]. Atr‐
deficient EGL cells underwent p53‐
independent proliferation arrest, while
other areas underwent p53‐dependent
apoptosis [Lee et al., 2012b]. Further-
more, co‐incident inactivation of Atm
was unexpectedly found not to exacer-
bate Atr loss in the brain, suggesting a
non‐overlapping role for each kinase
in this developmental context [Lee
et al., 2012b].
Topoisomerase II binding protein I
(TopBP1) is essential for DNA replica-
tion and cell cycle checkpoint activation
[Sokka et al., 2010]. It also plays a key
role in activating ATR kinase [Kumagai
et al., 2006]. Interestingly, conditional
progenitor‐restricted deletion of Topbp1
was found to be essential for early
progenitor genome stability and survival,
but not, unexpectedly, for replication per
se [Lee et al., 2012a]. Furthermore, this
impact was found to be p53‐dependent
whilst Atm‐independent [Lee et al.,
2012a]. Atm has previously been shown
to be an important mediator of p53‐
dependent DSB‐induced apoptosis in
the nervous system [Herzog et al., 1998].
Collectively, these findings highlight the
importance of the cell‐specific context
within the brain, along with the nature
of the genomic instability (e.g., replica-
tion fork‐dependent), as being funda-
mental to the precise impacts of defects
in DDR‐signaling controllers such as
Atr, Atm and Topbp1, in the developing
mouse brain at least.DEFECTIVE DNA DOUBLE
STRAND BREAK [DSB]
REPAIR AND
MICROCEPHALY
Non‐homologous DNA End‐Joining
(NHEJ) and Homologous Recombina-
tion Repair (HRR) are the core DSB
repair pathways [O’Driscoll and Jeggo,
2006; Moynahan and Jasin, 2010;
Deriano and Roth, 2013]. Interestingly,
Figure 4. Defective DDR andDNA repair as a cause of congenital microcephaly. (A) Neuroanatomical images of theATRIP‐mutated
Seckel syndrome individual described by [Ogi et al., 2012]. The patient is severely microcephalic [10 SD] with evidence of an abnormally
shaped pituitary (without an obvious fossa). (Images courtesy of Dr. Margaret Barrow). (B) Homologous recombination repair (HRR) from a
DSB is initiated by exonunclease‐mediated resection of the DSB ends. These RPA‐coated single stranded overhangs are then bound by
RAD51 generating a filament structure that can invade the sister chromatid to form aD‐loop. The crossover point is referred to as a Holliday
Junction (HJ). Template driven replication occurs and is followed by second end capture to generate a crossover containing a double HJ
(dHJ). This intertwined molecule requires resolution which can occur via BLM helicase‐dependent route, which generates a non‐crossover
product, or, a nuclease‐dependent route to generate a cross‐over. The nucleases that can act on this structure are termed “resolvases.” (C) An
on‐going DNA replication fork is shown with the parental DNA in black and the newly replicated DNA in blue. If this structure collides
with a DNA single strand break (SSB) the resultant product can contain a DNA double strand break (DSB). This situation requires the
coordinate action of DDR mechanisms and distinct DNA repair pathways. The same situation can also occur if an active or moving
transcription fork was to collide with a SSB. (D) Some of the damaged or modified DNA strand ends that can occur following oxidative
damage to DNA. The normal end polarity of a 50 phosphate and 30 hydroxyl groupmust be restored in order to allowenzymatic ligation of a
break. Topo I denotes a stabilized Topoisomerase I cleavable complex (CC) which is a normal intermediate in Topo I’s action on DNA. This
enzyme normally introduces a SSB to release torsional tension ahead of on‐going replication and transcription forks. These breaks are
normally dealt with by the SSBR machinery.
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anisms are frequently associated with
congenital microcephaly [O’Driscoll
and Jeggo, 2008]. Mouse studies suggest
that both pathways are essential for
developmental viability in mammals;
an indication that substantial levels of
spontaneous DSBs can be generated
during development [Symington and
Gautier, 2011]. NHEJ involves direct re‐
ligation of DSBs, sometimes necessitat-
ing processing of damaged base and/or
sugar moieties at DSB termini prior toligation [Deriano and Roth, 2013]. This
processing can potentially result in the
loss of genetic material. HRR on the
other‐hand requires the presence of a
sister chromatid to act as a template for
repair via strand invasion from one end
of the DSB during Holliday Junction
(HJ) formation [Heyer et al., 2010]
(Fig. 4B). Therefore, this pathway has
been assumed to only be operational
during cell cycle phases where a sister
chromatid is present (i.e., late S‐G2‐M)
[Symington and Gautier, 2011].Non‐Homologous DNA
End‐Joining [NHEJ]
NHEJ is required for immunoglobin
and T cell receptor generation via the
V(D)J and Class Switch Recombination
mechanisms [Gellert, 2002]. Therefore,
congenital defects in NHEJ pathway
components are also frequently associat-
ed with variable immunodeficiency,
ranging from variable/combined immu-
nodeficiency to severe combined immu-
nodeficiency [O’Driscoll and Jeggo,
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identified in PRKCD encoding DNA‐
PKcs,DCLRE1C encoding ARTEMIS,
LIG4 encoding DNA ligase IV and the
genes encoding XRCC4 and XLF/
Cernunnos [Moshous et al., 2001;
O’Driscoll et al., 2001; Buck et al.,
2006; van der Burg et al., 2009; Wood-
bine et al., 2013; Murray et al., 2014;
Shaheen et al., 2014]. Interestingly,
ARTEMIS‐defective patients, uniquely
in this context, do not appear to exhibit
microcephaly, in contrast to the other
genes [Moshous et al., 2001]. This may
be a consequence of the magnitude and
nature of their DSB repair; ARTEMIS‐
defective cells exhibit a specific DSB
repair in heterochromatin; an ATM‐
dependent process [Riballo et al., 2004].Homologous Recombination
Repair
By contrast to NHEJ, congenital defects
in core components of the HRR
machinery are still relatively rare in
humans, although some isolated germ‐
line defects have been described [re-
viewed in O’Driscoll, 2012]. Recent
examples include XRCC2 in a patient
exhibiting fanconi anemia (FA),
BRCA1 in a woman with early onset
ovarian cancer and microcephaly, and
BRCA2 in the context of MPD [Sham-
seldin et al., 2012; Domchek et al., 2013;
Shaheen et al., 2014]. FA patients
frequently exhibit congenital micro-
cephaly although bone marrow failure
and acute myeloid leukaemia develop-
ment are the typically invariant features
of this condition [Kee and Andrea,
2012]. The FA pathway is functionally
integrated with HRR and defects in
other core HRR components have
emerged clinically as FA; the classical
example being BRCA2 mutations in
FA individuals of the FANC‐D1 com-
plementation group [Moldovan and
D’Andrea, 2009; Kim and D’Andrea,
2012]. Other examples include
RAD51C (FANC‐O), PALB2, encod-
ing the BRCA2 interacting protein
(FANC‐N) and SLX4 (FANC‐P), en-
coding a component of the SLX4‐SLK1
HJ resolving endonuclease (Fig. 4B).
Interestingly, germ‐line mutations (het-erozygous) in the HRR genesRAD51C
and RAD51D have been identified in
breast and ovarian cancer cohorts
[Meindl et al., 2010; Loveday et al.,
2011, 2012; Shaheen et al., 2014]. This
suggesting that HRR defects can have a
highly variable clinical presentation.
Helicases and Nucleases
The Bloom syndrome helicase BLM
[RECQL3] plays an important role inHJ
resolution, and congenital microcephaly
can be marked in this condition
[Hickson, 2003; Croteau et al., 2014]
(Fig. 4B). Warsaw breakage syndrome, a
disorder of severe congenital microceph-
aly, growth retardation and chromosom-
al instability collectively reminiscent of
FA and the cohensinopathies, was found
to result from a mutation in another
ATP‐dependent DNA helicase,
CHLR1 (DDX11) [van der Lelij et al.,The Bloom syndrome helicase
BLM [RECQL3] plays an
important role in HJ
resolution, and congenital
microcephaly can be marked in
this condition. Warsaw
breakage syndrome, a disorder
of severe congenital
microcephaly, growth
retardation and chromosomal
instability collectively
reminiscent of FA and the
cohensinopathies, was found
to result from a mutation in
another ATP‐dependent
DNA helicase, CHLR1
(DDX11).2010; Capo‐Chichi et al., 2013]. This
helicase has been implicated in chromo-
some cohesion and in the recovery
of replicating cells from DNA damage
[Shah et al., 2013]. DNA2 is a helicase‐nuclease implicated inOkazaki fragment
processing and the processing of abnor-
mally structured replication forks (e.g.,
aberrant recombination intermediates)
[Mimitou and Symington, 2009; Kang
et al., 2010]. A truncating DNA2
mutation has recently been identified
in a consanguineous MPD family
[Shaheen et al., 2014]. This category
of defect reinforces the concept that an
impaired ability to process DNA breaks
during DNA replication may represent
a contributing pathomechanism to con-
genital microcephaly.
Prior to RAD51‐mediated strand
invasion to establish HJs during HRR,
DSBs in S‐G2 undergo resection
(Fig. 4B). Various exonucleases have
been implicated in this process, one
of best known being the MRE11‐
RAD50‐NBN (M‐R‐N) complex [Sy-
mington and Gautier, 2011]. ATM
directly phosphorylates each component
of this complex following DSB forma-
tion. Mutations in all M‐R‐N compo-
nents have now been identified in
clinically overlapping human disorders
exhibiting congenital microcephaly. De-
fects in NBN encoding Nibrin/NBS1
cause Nijmegen breakage syndrome
(NBS), a disorder of congenital micro-
cephaly, growth restriction and haema-
tological malignancy [Carney et al.,
1998; Varon et al., 1998]. Defects in
RAD50 have been shown to cause an
NBS‐like disorder, whilst mutations in
MRE11 are associated with a clinical
spectrum ranging from A‐T‐Like Dis-
order (A‐T‐LD) without overt micro-
cephaly to an NBS‐like condition,
probably reflective of different geno-
type‐phenotype impacts [Stewart et al.,
1999; Waltes et al., 2009; Matsumoto
et al., 2011]. CtIP (CTBP‐interacting
protein) is another of these exonucleases
implicated in DSB resection [Mimitou
and Symington, 2009]. CtIP is encoded
by RBBP8 (retinoblastoma binding pro-
tein 8), wherein a hypomorphic muta-
tion has been described in a Seckel
syndrome kindred [Qvist et al., 2011].
Therefore, hypomorphic defects in
various exonucleases that function dur-
ing specific stages of DSB repair are
emerging as an underlying cause of
congenital microcephaly.
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Developing Brain: Spatial
Regulation and Checkpoint
Activation
As mentioned above, HRR is by its
nature of requiring a homologous DNA
strand as a template for repair, restricted
to specific phases of the cell cycle where
sister chromatids are available (i.e., S‐G2‐
M) (Fig. 4B). Therefore, tissues with a
very high replicative index would be
expected to rely heavily on this pathway
to repair DSBs, compared to non‐
replicative post‐mitotic tissues. Studies
using knockout embryonic mouse mod-
els of NHEJ and HRR have suggested
that both these DSB repair pathways
may have distinct spatiotemporal func-
tionality during neuronal development
[Orii et al., 2006]. Defective HRR
(Xrcc2)‐induced apoptosis appeared to
occur predominantly within the prolif-
erating neuronal precursors of the
ventricular zone (VZ) [Orii et al.,
2006] (Fig. 1A). In contrast, defective
NHEJ (Lig4)‐induced apoptosis appear-
ed restricted to the postmitotic differen-
tiating neurons of the subventricular
zone (SVZ) [Orii et al., 2006]. Work
using ionising radiation (IR)‐induced
DSBs in a hypomorphic Lig4 embryonic
mouse model (Lig4Y288C) has further
developed this concept by providing
evidence for a functional, but relatively
insensitive, G2‐M cell cycle checkpoint
in the VZ‐SVZ [Gatz et al., 2011]. This
insensitive checkpoint allows cells with
low numbers of DSBs to transit from the
VZ‐SVZ to the intermediate zone (IZ)‐
cortical plate (CP) region where they
then die by apoptosis [Gatz et al., 2011].
Interestingly, work in somatic cells has
shown that the DSB‐induced G2‐M
cell cycle checkpoint can be quite an
ineffective block to preventing cells with
modest levels of DSBs from entering
mitosis [Lobrich and Jeggo, 2007].Origins of Endogenous DNA
Breaks in the Developing Brain
A growing body of evidence now
indicates that the inability to repair
DSBs because of defects in NHEJ and/
or HRR clearly adversely impacts uponnormal neurogenesis often resulting
in congenital microcephaly [O’DriscollA growing body of evidence
now indicates that the
inability to repair DSBs
because of defects in NHEJ
and/or HRR clearly adversely
impacts upon normal
neurogenesis often resulting in
congenital microcephaly.and Jeggo, 2008; O’Driscoll, 2012].
There has been much speculation as to
what precisely could be the origin of
endogenous DSBs during neurogenesis.
One suspect, because of the high oxygen
consumption and metabolic rate of
neurons and their supportive cells, is
endogenously generated reactive oxy-
gen species (ROS)‐induced oxidative
DNA damage [Caldecott, 2008]. This
can result in base and ribose sugar
backbone damage/modifications, abasic
apurinic/apyrimidinic (AP) site forma-
tion (i.e., base loss) and even overt single
strand break (SSB) formation. These
lesions are rapidly dealt with by the
coordinated action of the base excision
repair (BER) and single strand break
repair (SSBR) pathways [Caldecott,
2008]. If an active DNA replication or
transcription fork encounters an SSB
there is an elevated risk of consequent
DSB formation (Fig. 4C).
Congenital defects in certain SSBR
components have been identified in
humans, but these are usually associated
with slowly progressive cerebellar de-
generation, ultimately presenting with
ataxia and peripheral neuropathy‐disor-
ders, rather than congenital microceph-
aly [Caldecott, 2008; O’Driscoll, 2012].
It is likely that active and complementary
DNA‐repair pathways co‐ordinately
play a protective role during neuro-
genesis in this context. One example of
a defect in a core SSBR component
where this complementarity may be
compromised is polynucleotide kinase‐phosphatase (PNKP). Multiple novel
mutations in PNKP were recently
described in several individuals exhibit-
ing severe primary microcephaly, devel-
opmental delay, hyperactivity and
seizures (MCSZ) [Shen et al., 2010].
Interestingly, PNKP’s dual kinase and
phosphatase activity, which is essential
for repair of the aberrantly modified
termini at strand breaks, is also implicat-
ed in NHEJ (Fig. 4D) [Caldecott, 2002;
Koch et al., 2004; Weinfeld et al., 2011].
Therefore, the marked congenital mi-
crocephaly in MCSZ may be more
reflective of combined attenuation of
both SSBR and DSB repair pathways.CONCLUDING REMARKS
Congenital microcephaly has a complex
underlying genetic basis, as demonstrat-
ed by the selection of defects discussed
here. An inability to divide and differ-
entiate effectively resides at the center of
this and there are multiple routes
through which these processes can be
disrupted. The growing number of
causative genetic defects described for
congenital microcephaly consolidates
the importance of mitotic spindle
organization and centrosome stability
in enabling the execution of precise
chromosome segregation during mito-
sis. Novel causative genetic defects also
provide evidence that perturbations of
other cell cycle phases are also relevant to
normal neurogenesis, for example,
DNA replication origin licensing, G1‐
S entry, DNA synthesis and efficient S‐
phase progression. The importance and
integration of functional cilia‐signaling
in the context of regulated cell cycle
entry and progression cannot be over-
stated. Finally, defects in multiple com-
ponents of the complex pathways that
control genome stability and integrity
via signal transduction and repair pro-
cesses are additional important contrib-
utors to congenital microcephaly.
Without doubt, the advent of
exome sequencing has greatly facilitated
the identification of novel microcepha-
ly‐causing defects, further developing
our understanding of the molecular basis
of this abnormality. This trend is likely to
continue. The consequent challenge in
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determining the pathogenicity of the
multitude of candidate variants derived
from such approaches. This issue is
compounded by the multigenic occur-
rence of variants, which is still likely an
under‐appreciated and under‐reported
situation at present [Agha et al., 2014].
Functional cellular biology using pa-
tient‐derived cell lines, model cell
systems (siRNA, shRNA, cDNA com-
plementation strategies) and even iPS
from patients’ cells, will likely continue
to remain the basic cornerstone ap-
proaches in helping to meet this chal-
lenge. The growing use of more cost‐
effective and rapidly growing model
organisms in this area, such as zebrafish, is
also likely to continue [Novorol et al.,
2013]. For now, mouse models remain
the effective ‘gold standard’ for neuro-
genic‐microcephaly research, but the
potential offered by the fascinating
cerebral organoid system represents a
very exciting future prospect [Lancaster
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